151 related articles for article (PubMed ID: 6177964)
1. Open assessment of the effect of prazosin on plasma lipids.
Havard CW; Khokhar AM; Flax JS
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
Gemma G; Montanari G; Suppa G; Paralovo A; Franceschini G; Mantero O; Sirtori CR
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S233-7. PubMed ID: 6177963
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
Joglekar SJ; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
[TBL] [Abstract][Full Text] [Related]
4. Effect of prazosin on lipoprotein metabolism in premenopausal, hypertensive women.
Lithell H; Waern U; Vessby B
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S242-4. PubMed ID: 6177965
[TBL] [Abstract][Full Text] [Related]
5. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
Velasco M; Silva H; Morillo J; Pellicer R; Urbina-Quintana A; Hernández-Pieretti O
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S225-7. PubMed ID: 6177961
[TBL] [Abstract][Full Text] [Related]
6. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H
Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787
[TBL] [Abstract][Full Text] [Related]
7. Effect of prazosin on serum lipids.
Kokubu T; Itoh I; Kurita H; Ochi T; Murata K; Yuba I
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S228-32. PubMed ID: 6177962
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
Hanon O; Giacomino A; Troy S; Bernaud C; Girerd X; Weber S
Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
Yashiro A; Sugano M; Nakashima Y; Tasaki H; Kuroiwa A
Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
[TBL] [Abstract][Full Text] [Related]
11. Dose requirement and effect of nicardipine on lipid profile in mild to moderate essential hypertensives.
Tariq AR; Maheendran K; Kamsiah J; Christina P
Med J Malaysia; 1992 Sep; 47(3):182-9. PubMed ID: 1491643
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid levels in hypertensive patients during captopril treatment.
Nishide T; Shirai K; Shinomiya M; Ishikawa Y; Murano S; Morisaki N; Saito Y; Yoshida S; Sasaki N
Clin Ther; 1989; 11(6):820-7. PubMed ID: 2692824
[TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
14. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
Pessina AC
Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
[TBL] [Abstract][Full Text] [Related]
15. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
16. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
Sasaki J; Handa K; Arakawa K
Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
[TBL] [Abstract][Full Text] [Related]
17. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
Farsang C; Péter M; Balás-Eltes A; Fehér J
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S240-3. PubMed ID: 2455187
[TBL] [Abstract][Full Text] [Related]
18. Prazosin lowers plasma triglyceride concentration in rats: a preliminary report.
Reaven GM; Dall'Aglio E
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S248-50. PubMed ID: 6177967
[TBL] [Abstract][Full Text] [Related]
19. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
20. Lipid profile improvement following celiprolol.
Herrmann JM; von Heyman F; Freischütz G
J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
